(Back, L-R) Bernard Stang, Maurie Stang (Chairman), Steven Kritzler
(Front, L-R) Huw Jones (Chief Executive Ofiicer), Robert Waring (Company Secretary)

Maurie Stang
Non-Executive Chairman
Mr Stang is Chief Executive Officer of the Regional Health Care group of companies and of Novapharm Research. He has a 25 year track record of building and managing successful companies in the Australian healthcare market and extensive networks within the life-sciences and pharmaceutical sectors, both in Australia and internationally.

Since co-founding the Regional Health Care group, Mr Stang has been instrumental in building it into one of the region's leading healthcare product suppliers, with a key joint venture in the Australasian dental market and successful operating businesses across a range of medical, pharmaceutical and consumer healthcare sectors. Mr Stang is a Director and shareholder of Novapharm Research and of Nanosonics and is the founder of Gryphon Capital. Director since 2002; appointed Chairman 2002.

Huw Jones
Executive Director
Chief Executive Officer
Prior to joining Aeris Environmental in 2004, Mr Jones worked as Managing Director, Australasia of Datex Ohmeda (now GE Healthcare), a $1bn global, high technology equipment manufacturer and business-to-business supplier, operating in the healthcare sector.

Mr Jones holds a First Class Degree in Civil Engineering and an MBA from the London Business School and is a non-executive director of Nascor Pty Ltd, a specialty medical equipment company. Director since 2005; appointed Chief Executive Officer 2005.

Steven Kritzler
Non-Executive Director (Since February 2005)
Acting Chief Executive Officer (to February 2005)
Mr Kritzler is the Technical Director of Novapharm Research. He has some 35 years experience in commercial R&D in the areas of pharmaceutical, medical, cosmetic and specialty industrial products. Under Mr Kritzler's technical direction, Novapharm Research has become a world-leader in infection control science.

Novapharm Research has become a world-leader in infection control science. Mr Kritzler has an M.Sc from UNSW in the field of Polymer Chemistry and holds a number of international patents. Mr Kritzler is a director and shareholder of a number of international patents. Mr Kritzler is a director and shareholder of Novapharm Research and of Nanosonics. Director since 2002.

Bernard Stang
Non-Executive Director
Mr Stang is co-founder and chairman of the Regional Health Care group of companies. He also chairs a number of private companies in the medical sector. Mr Stang manages a broad portfolio of investments in the private and listed sectors and has enjoyed over thirty years operational leadership in successful healthcare businesses.

Mr Stang is CEO of property development investment company Stangcorp Pty Ltd, which has been involved in various retail, commercial and industrial property prior to co-founding the Regional Health Care group of companies. Mr Stang is a director and shareholder of Novapharm Research and of Nanosonics. Director
since 2002.

Robert Waring
Company Secretary
Mr Waring BEc, CA, FCIS, ASIA, FAICD was appointed to the position of Company Secretary in 2002. Mr Waring's experience has been gained over 33 years in financial and corporate roles including 15 years in company secretarial roles for ASX listed companies and 11 years as a director of an ASX listed company.

Mr Waring has had 23 years in industry and prior to that, nine years with an international firm of chartered accountants. He is a director of Oakhill Hamilton Pty Ltd, a company which provides secretarial and corporate advisory services to a range of listed and unlisted companies.